Experimental models of pulmonary embolism
Pulmonary embolism (PE) ranks third in the structure of acute cardiovascular diseases. Every year there is a rapid increase in morbidity and mortality from PE. Laboratory biomarkers for PE diagnosis do not have the necessary specificity, and therefore are ineffective. PE requires timely active treat...
Main Authors: | I. S. Mullova, A. M. Chaulin, A. I. Svechkov, T. V. Pavlova, L. V. Limareva, D. V. Duplyakov |
---|---|
Format: | Article |
Language: | Russian |
Published: |
«FIRMA «SILICEA» LLC
2022-03-01
|
Series: | Российский кардиологический журнал |
Subjects: | |
Online Access: | https://russjcardiol.elpub.ru/jour/article/view/4887 |
Similar Items
-
Prognostic Value of ECG in Patients with Pulmonary Embolism
by: I. S. Mullova, et al.
Published: (2019-03-01) -
Thrombolytic Therapy in Normotensive Patients with Pulmonary Embolism (Data from the Retrospective Study)
by: N. A. Сherepanova, et al.
Published: (2020-11-01) -
Novel biological markers for the diagnosis and prediction of mortality risk in patients with pulmonary embolism
by: A. A. Podlipaeva, et al.
Published: (2021-01-01) -
Validation of the SIRENA score for assessing the risk of inhospital mortality in patients with acute pulmonary embolism in an independent sample
by: N. A. Cherepanova, et al.
Published: (2022-06-01) -
GRACE score in assessing the risk of hospital outcomes in patients with pulmonary embolism
by: I. S. Mullova, et al.
Published: (2018-12-01)